GW501516,GW-501,516, GW1516, GSK-516

GW501516 (also known as GW-501,516, GW1516, GSK-516 and on the black market as Endurobol is a PPARδ receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate for metabolic diseases and cardiovascular diseases, and was abandoned in 2007 because animal testing showed that the drug caused cancer to develop rapidly in several organs.<br /><br />In 2007 research was published showing that high doses of GW501516 given to mice dramatically improved their physical performance; the work was widely discussed in popular media, and led to a black market for the drug candidate and to its abuse by athletes as a doping agent. The World Anti-Doping Agency (WADA) developed a test for GW501516 and other related chemicals and added them to the prohibited list in 2009; it has issued additional warnings to athletes that GW501516 is not safe.<br /><br /> <br /><br /><br /><br />Our promise:<br /><br /> <br /><br />1. Good quality product and reasonable price, make customers happy and save customers’ money.<br /><br />2. Delivery product on time, save customers’ time<br /><br />3. Professional packing, let the customers receive it successfully<br /><br />4. Many payment instruments, convenient to pay<br /><br />5. Service customers forever, to establish long-time cooperation relationship<br /><br /> <br /><br />Welcome to your inquire and suggestions, everyone here do the best for you!<br /><br /><br /><br />